Lingering inflammation in the colon is a known risk factor for colorectal cancer and now scientists report in the journal Cell Reports that one way it resets the stage to enable this common and often deadly cancer.
Inflammation is supposed to be a short-term response to an infection or other irritant in the body that is essential to eliminating it. But when inflammation persists, it can contribute to a myriad of common conditions, from cancer to cardiovascular disease.
The chronic inflammation of ulcerative colitis prompts high levels of myeloid-derived suppressor cells, or MDSCs, to accumulate in the colon. High levels of MDSCs, in turn, produce higher levels of IL-10, a cytokine known to suppress inflammation. But at this high level, the function of IL-10, like the environment in the colon, changes. IL-10 instead activates STAT3, a protein that works as a gene regulator, which in turn increases expression of two genes - DNMT1 and DNMT3b - in the colon. These genes alter the DNA of and ultimately silence a tumor suppressor called interferon regulator factor 8, or IRF8.
Next steps include finding ways to inhibit high expression of IL-10 in the colon."IL-10 has a dual function. It can either be promoting or interfering with an immune response," says the senior author. "What we found here is IL-10 promotes colon cancer."
In a healthy state, IL-10 and IRF8 have no known interaction but both work in different ways to protect against invaders, the senior author.
The scientists set out to look at whether and how the two are connected in a chronically inflamed colon and test the hypothesis that IRF8 functions as a colorectal cancer suppressor.
They created a mouse missing IRF8 in the epithelial cells that line the colon and found plenty of evidence to support their hypothesis. The mice were much more susceptible to chronic inflammation, had less normal cell death in this high-cell turnover area and got more tumors. They also found that in the face of chronic inflammation, IRF8 is silenced, and that in human cancer, IRF8 is downregulated compared to normal colon tissues.
Meanwhile, they showed that in this altered environment, MDSCs and the IL-10 they produce were at higher levels and so were the two genes that ultimately silence IRF8. They found the same shifts in human colon cancer.
The author says it's likely the high levels and timing that transform the role of IL-10 from suppressor of inflammation to suppressor of IRF8.
http://jagwire.augusta.edu/archives/60242
https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31813-8
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmyeloid-derived_2&filter=22
Latest News
Personalized brain modeling…
By newseditor
Posted 29 Jan
Afternoon chemotherapy impr…
By newseditor
Posted 29 Jan
Propionic acid protects ner…
By newseditor
Posted 28 Jan
How cells prevent harmful e…
By newseditor
Posted 28 Jan
Structured cerebellar conne…
By newseditor
Posted 28 Jan
Other Top Stories
Genetic architecture of the human gray matter
Read more
Genetics links high blood pressure and obesity to reduced lifespan
Read more
A gene mutation enhances cognitive flexibility in mice
Read more
Inherited origin of prostate cancer in families
Read more
A gene mutation either slows or accelerates ALS
Read more
Protocols
Machine learning prediction…
By newseditor
Posted 09 Jan
Differentiating PC12 cells…
By newseditor
Posted 09 Jan
Ultrasensitive sensors reve…
By newseditor
Posted 05 Jan
In vitro-derived medium spi…
By newseditor
Posted 04 Jan
Molecular and spatial signa…
By newseditor
Posted 30 Dec
Publications
HIF-1a accumulation in resp…
By newseditor
Posted 29 Jan
Electrical signals in the E…
By newseditor
Posted 29 Jan
Parathyroid hormone recepto…
By newseditor
Posted 29 Jan
Plasma biomarker profiles i…
By newseditor
Posted 29 Jan
Chemotherapy delivery time…
By newseditor
Posted 29 Jan
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar